| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |